All India Institute of Medical Sciences, New Delhi, India. RATIONALE: Trauma disrupts the balance of the pro-and anti-inflammatory immune response. The inflammatory response following trauma is dependent on the severity of injury. We hypothesized that trauma evokes a Th-9, Th-22 and T-regulatory type of immune response, which has a central role in the post-trauma immunopathogenesis, tissue healing and the outcome of trauma patients. METHODS: A cohort of 30 non-referred, polytrauma survivors based on the injury severity score (ISS) and 30 aged-matched healthy controls (18-65 years old) at JPNA Trauma center were studied. Two equal sub-cohorts were defined as Minor (ISS<15) and major (ISS>15) trauma. Whole blood analysis was done using multicolor flow cytometry to study the frequencies of Th-9 (CD4+ IL9+), Th-22 (CD4+IL22+) and T-regulatory (CD4+TGFb+) cells: within 24 hours (day 0), and day 2, day 5, day 10 of injury & on the day of discharge. The cell frequencies were compared inter-group and with healthy controls. All patients were clinically followed-up till their outcome at the hospital. RESULTS: Following minor trauma, a higher Th-9 (0.08-29.58%; p50.01) & Th-22 (0.77-5.95%; p50.03) and T-regulatory (0-1.46%; p <0.001) responses were observed. While, in major trauma patients, a lower Th-9 (0.08-9.08%; p50.01) and Th-22 (0.62-4.51%; p50.02), and predominant & consistent T-regulatory (3.80-9.44% p50.001) cell responses were observed. CONCLUSIONS: Minor injuries evoked a higher Th-9 & Th-22 response while severe injuries induced a predominant T regulatory cell response. There was a positive correlation between the frequency of T-regulatory cells and severity of injury. George Washington University School of Medicine, Washington, DC. RATIONALE: Muramyl peptides are structural bacterial components which act via NOD2 pattern-recognition receptors to increase neutrophil, monocyte and macrophage cytotoxic activity. METHODS: GMDP (N-acetylglucosamine-1-4-N-acetylmuramylalanyl-D-isoglutamine derived from bacterial cells walls-a NOD2 receptor agonist) modulation of specific anti-ragweed IgE antibody production in mice was studied by passive cutaneous anaphylaxis Total IgE concentration after 7 days cultivation from PBMC supernatants of 12 patients with seasonal and perennial rhinitis, 7 patients with moderate persistent asthma and 12 healthy donors was assessed by Phadia CAP methods. IL-1b, Il-4, TNF-a, GM-CSF, IFN-g in sera of immunocompromised and allergic patients exposed to GMDP was assessed by ELISA. RESULTS: GMDP modulated IL-1b, IL-4, TNF-a, GM-CSF, gIFN cytokine production by neutrophils, monocytes and macrophages. GMDP decreases IgE production by PBMC of healthy donors with 3-fold greater decrease in patients with rhinitis and asthma (p< 0.001). In ragweed immunized mice, GMDP decreased synthesis of specific antiragweed IgE more than 3 fold. In allergic patients GMDP decreased IL-4 levels from 18.35 to 10.45 pg/ml (p < 0.01), while gINF increased from 11.7 to 13.9 pg/ml (p < 0.05). GMDP dose-dependently increased gINF levels 3-8 fold and decreased IL-4 levels in asthmatics. CONCLUSIONS: GMDP in secondary immunodeficiency patients modulated production of IL-1b, TNF-a, GM-CSF, gIFN by phagocytes. GMDP decreased production of total IgE in allergic patients and down-regulated allergen-specific IgE antibody synthesis in mice. GMDP induced a switch from Th2 to Th1 responses causing increased gINF and decreased IL-4.
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The Role of SP-D in Dendritic Cell Induced T-Cell Activation Austin M. Van Haren, Sarah Killingbeck, Wenxiu Qu, Erik D. Larson, Moyar Qing Ge, PhD, Cameron H. Flayer, and Angela Haczku, MD PhD FAAAAI; University of California Davis, Davis, CA. RATIONALE: Our lab has previously showed that the immunoprotective lung collectin, SP-D suppresses proinflammatory dendritic cell activation. SP-D however was also shown to be an opsonin with importance in foreign antigen uptake by phagocytes. The role of SP-D in dendritic cell-driven T cell activation remains unclear. METHODS: Uptake of intranasally instilled fluorescent apoptotic bodies by dendritic cells was studied by immunochemistry and FACS analysis using lung cells of WT C57BL/6 and SP-D-/-mice. Bone-marrow cells were isolated and cultured with mucosal differentiating cytokines including 200 ng/mL Flt3L for 10 days. WT C57BL/6 mice were sensitized to ovalbumin (OVA) and alum and splenocytes were harvested after an intranasal challenge 13 days later. Splenocytes were put into culture in vitro with the mitogen PHA or OVA at varying concentrations in the presence or absence SP-D (0.1-10 mg/mL). T cell proliferation was assessed by a BrdU ELISA. RESULTS: Lack of SP-D in gene deficient mice was associated with increased number of TNF-ɑ+ CD11b+ DCs in the lung. These activated DCs had a diminished capability of engulfing apoptotic bodies suggesting that SP-D is necessary for increasing phagocytic capabilities of lung DCs. CD11c+ BMDCs grown with Flt3L preferentially expressed CD103 (as opposed to CD11b) and MHC II. T cell proliferation was diminished by recombinant SP-D (starting at 0.1 mg/mL). CONCLUSIONS: These data indicate that SP-D plays a specific immunemodulatory role by inhibiting antigen and mitogen-induced T cell proliferation and decreasing inflammatory activation while increasing antigen sequestering function of DCs.
